Norges Bank’s Edgewise Therapeutics EWTX Stock Holding History

Norges Bank’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.7M	Buy	+510,140	New	+$17.6M	﹤0.01%	1216
2026 Q1	–	Sell	-751,355	Closed	-$18.6M	–	475
2025 Q4	$18.6M	Buy	+751,355	New	+$15.1M	﹤0.01%	1235
2025 Q3	–	Sell	-47,755	Closed	-$626K	–	534
2025 Q2	$626K	Hold	47,755	–	–	﹤0.01%	1599
2025 Q1	$1.05M	Hold	47,755	–	–	﹤0.01%	1619
2024 Q4	$1.28M	Hold	47,755	–	–	﹤0.01%	1735
2024 Q3	$1.27M	Buy	+47,755	New	+$950K	﹤0.01%	1706
2022 Q2	–	Sell	-301,691	Closed	-$2.93M	–	2093
2022 Q1	$2.93M	Hold	301,691	–	–	﹤0.01%	1938
2021 Q4	$4.61M	Hold	301,691	–	–	﹤0.01%	1923
2021 Q3	$5.01M	Hold	301,691	–	–	﹤0.01%	1929
2021 Q2	$6.43M	Sell	301,691 -147,309	-33%	-$4.03M	﹤0.01%	1859
2021 Q1	$14.6M	Buy	+449,000	New	+$14.6M	﹤0.01%	1662

Other funds holding EWTX

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Norges Bank's EWTX Position: Q2 2026 in Review

Norges Bank opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 510,140 shares worth $20.7M. The stake represents ﹤0.01% of the portfolio and ranks #1216 among its holdings. This is a return to the name: Norges Bank previously reported a position in EWTX as recently as Q4 2025.

Norges Bank first reported a position in EWTX in Q1 2021 and has held it in 11 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

Norges Bank held 510,140 shares of Edgewise Therapeutics worth $20.7M as of Q2 2026.
Edgewise Therapeutics was a new Norges Bank position in Q2 2026.
Edgewise Therapeutics made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1216 holding.
Norges Bank first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 11 quarters since.
226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.